Status:
COMPLETED
Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis
Lead Sponsor:
Sisli Hamidiye Etfal Training and Research Hospital
Conditions:
Kidney Failure
Renal Insufficiency, Chronic
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Double blinded, randomized controlled trial evaluating medium cut-off dialyzer compared to high flux dialyzer in ironic hemodialysis patients over a 6 months period with 3 months crossovers.
Eligibility Criteria
Inclusion
- patients who are older than 18 years and younger than 65 years
- patient with end-stage renal disease, hemodialysis more than 6 months
- patients under hemodialysis with high-flux dialyzer more than 3 months
- patients willing to participate after given fair and clear information about study
Exclusion
- patients living with Hepatitis B or C,
- patients with malignancy
- patients under immunosuppressive treatment
- patients with autoimmune diseases such as systemic lupus erythematosus, etc.
- patients with active infections
- patients planned to have a kidney transplantation in 6 months
- patients having vascular access problems
- patients planned to transfer to another center
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03836508
Start Date
September 1 2018
End Date
July 1 2019
Last Update
March 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sisli Hamidiye Etfal Training and Research Hospital
Istanbul, Turkey (Türkiye)